ESC 365 - The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia.

ESC Premium Access

The cardioprotective potential of soluble urokinase Plasminogen Activator Receptor (suPAR) in myocardial ischemia.

Session: Platelets and thrombosis: novel experimental aspects

Topic: Cardiac Biology and Physiology

Speaker: Mr T. Pirker (Christchurch, NZ)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Mr Thomas Pirker

Christchurch (New Zealand)

0 follower

4 more presentations in this session

Sphingosine-1-phosphate reduces arterial thrombosis via enhanced endothelial thrombomodulin expression by S1PR1 signaling

Speaker: Doctor M. Benkhoff (Duesseldorf, DE)

Single-cell mass cytometry analysis unveils prothrombotic expression and heterogeneity in essential thrombocythemia

Speaker: Doctor S. Kuehne (Augsburg, DE)

Thrombin generation, fibrin clot permeation and lysis in patients with severe mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair: mitral fibrin study.

Speaker: Doctor A. Siniarski (Krakow, PL)

Direct IL-6 inhibition prevents arterial thrombosis by reducing collagen-mediated platelets activation

Speaker: Doctor S. Ministrini (Zurich, CH)

Access the full session

Platelets and thrombosis: novel experimental aspects

Speakers: Mr T. Pirker, Doctor M. Benkhoff, Doctor S. Kuehne, Doctor A. Siniarski, Doctor S. Ministrini

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources